{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:36:47Z","timestamp":1753886207314,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In this study considering the relationship between serum endocan and CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score, we assumed that endocan level could be a new biomarker for stroke risk in patients with paroxysmal atrial fibrillation (PAF). It was examined that endocan could be an alternative to determine the risk of stroke and anticoagulation strategy in patients with PAF. The CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc scores were calculated for 192 patients with PAF, and their serum endocan levels were measured. The patients were divided into two groups as those with low to moderate (0-1) and those with high (\u2265 2) CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc scores, and the endocan levels were compared between these two groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The serum endocan level was significantly higher in the high CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score group (<jats:italic>p<\/jats:italic>&lt; 0.001). In the multivariate logistic regression analysis, endocan, C-reactive protein, and low-density lipoprotein were found to be independent determinants of the CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score. The predictive value of endocan was analyzed using the ROC curve analysis, which revealed that endocan predicted a high stroke risk (CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc \u2265 2) at 82.5% sensitivity and 71.2% specificity at the cutoff value of 1.342.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study indicates that endocan is significantly associated with CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score. We demonstrated that endocan could be a new biomarker for the prediction of a high stroke risk among patients diagnosed with PAF.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s43044-021-00132-1","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T13:02:53Z","timestamp":1610629373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The relationship of the serum endocan level with the CHA2DS2-VASc score in patients with paroxysmal atrial fibrillation"],"prefix":"10.1186","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-5713","authenticated-orcid":false,"given":"G\u00f6khan","family":"Ceyhun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,14]]},"reference":[{"key":"132_CR1","unstructured":"January CT, Wann LS, Alpert JS et al (2014) ACC\/AHA task force members. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation. 130(23):2071\u20132104"},{"key":"132_CR2","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1161\/STROKEAHA.117.018551","volume":"48","author":"TH Kim","year":"2017","unstructured":"Kim TH, Yang PS, Kim D et al (2017) CHA2DS2-VASc score for identifying truly low-risk atrial fibrillation for stroke: a Korean Nationwide cohort study. Stroke. 48:2984\u20132990","journal-title":"Stroke."},{"key":"132_CR3","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1161\/STROKEAHA.115.010947","volume":"46","author":"K Takabayashi","year":"2015","unstructured":"Takabayashi K, Hamatani Y, Yamashita Y et al (2015) Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: the Fushimi atrial fibrillation registry. Stroke. 46:3354\u20133361","journal-title":"Stroke."},{"key":"132_CR4","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1016\/j.ijcard.2012.06.118","volume":"167","author":"A Banerjee","year":"2013","unstructured":"Banerjee A, Taillandier S, Olesen JB et al (2013) Pattern of atrial fibrillation and risk of outcomes: the Loire Valley atrial fibrillation project. Int J Cardiol 167:2682\u20132687","journal-title":"Int J Cardiol"},{"key":"132_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263\u2013272","journal-title":"Chest"},{"issue":"38","key":"132_CR6","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. EurHeart J 37(38):2893\u20132962","journal-title":"EurHeart J"},{"key":"132_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/10520295.2011.577754","volume":"87","author":"SM Zhang","year":"2012","unstructured":"Zhang SM, Zuo L, Zhou Q et al (2012) Expression and distribution of endocan in human tissues. Biotech Histochem 87:172\u2013178","journal-title":"Biotech Histochem"},{"key":"132_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4103\/0253-7613.144891","volume":"46","author":"A Kali","year":"2014","unstructured":"Kali A, Shetty KSR (2014) Endocan: a novel circulating proteoglycan. Indian J Pharm 46:579\u2013583","journal-title":"Indian J Pharm"},{"key":"132_CR9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/jcp.24485","volume":"229","author":"W Lee","year":"2014","unstructured":"Lee W, Ku S-K, Kim S-W et al (2014) Endocan elicits severe vascular inflammatory responses in vitro and in vivo. J Cell Physiol 229:620\u2013630","journal-title":"J Cell Physiol"},{"key":"132_CR10","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/ki.2014.227","volume":"86","author":"MI Yilmaz","year":"2014","unstructured":"Yilmaz MI, Siriopol D, Saglam M et al (2014) Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. Kidney Int 86:1213\u20131220","journal-title":"Kidney Int"},{"issue":"3","key":"132_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1089\/gtmb.2014.0274","volume":"19","author":"XS Wang","year":"2015","unstructured":"Wang XS, Yang W, Luo T et al (2015) Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension. Genet Test Mol Biomarkers 19(3):124\u2013127","journal-title":"Genet Test Mol Biomarkers"},{"issue":"7","key":"132_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1177\/0003319717740781","volume":"69","author":"I Balamir","year":"2018","unstructured":"Balamir I, Ates I, Topcuoglu C et al (2018) Association of endocan, ischemia-modified albumin, and hsCRP levels with endothelial dysfunction in type 2 diabetes mellitus. Angiology. 69(7):609\u2013616","journal-title":"Angiology."},{"key":"132_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/0003319716646932","volume":"68","author":"H Kundi","year":"2016","unstructured":"Kundi H, Balun A, Cicekoglu H et al (2016) Admission endocan level may be a useful predictor for in-hospital mortality and coronary severity index in patients with ST segment elevation myocardial infarction. Angiology. 68:46\u201351","journal-title":"Angiology."},{"key":"132_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/JIM.0000000000000219","volume":"63","author":"C Xiong","year":"2015","unstructured":"Xiong C, Zhao ZW, Chen ZY et al (2015) Elevated human endothelial cell-specific molecule-1 level and its association with coronary artery disease in patients with hypertension. J Invest Med 63:867\u2013870","journal-title":"J Invest Med"},{"key":"132_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2015.09.030","volume":"243","author":"S Balta","year":"2015","unstructured":"Balta S, Mikhailidis DP, Demirkol S et al (2015) Endocan: a novel inflammatory indicator in cardiovascular disease? Atherosclerosis. 243:339\u2013343","journal-title":"Atherosclerosis."},{"key":"132_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/europace\/eur241","volume":"14","author":"P Kirchhof","year":"2012","unstructured":"Kirchhof P, Lip GY, Van Gelder IC et al (2012) Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options\u2014a report from the 3rd atrial fibrillation competence NETwork\/European heart rhythm association consensus conference. Europace 14:8\u201327","journal-title":"Europace"},{"key":"132_CR17","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1161\/01.CIR.0000039327.11661.16","volume":"106","author":"H Cai","year":"2002","unstructured":"Cai H, Li Z, Goette A et al (2002) Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation. 106:2854\u20132858","journal-title":"Circulation."},{"key":"132_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/hrt.2007.135277","volume":"95","author":"M Guazzi","year":"2009","unstructured":"Guazzi M, Arena R (2009) Endothelial dysfunction and pathophysiological correlates in atrial fibrillation. Heart. 95:102\u2013106","journal-title":"Heart."},{"key":"132_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013407","volume":"97","author":"T Zhao","year":"2018","unstructured":"Zhao T, Kecheng Y, Zhao X et al (2018) The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease: a meta-analysis. Medicine (Baltimore) 97:e13407","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"132_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/cvr\/cvv001","volume":"105","author":"RS Wijesurendra","year":"2015","unstructured":"Wijesurendra RS (2015) Casadei B atrial fibrillation: effects beyond the atrium? Cardiovasc Res 105(3):238\u2013247","journal-title":"Cardiovasc Res"},{"key":"132_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1253\/circj.66.583","volume":"66","author":"N Takahashi","year":"2002","unstructured":"Takahashi N, Ishibashi Y, Shimada T et al (2002) Impaired exercise-induced vasodilatation in chronic atrial fibrillation: role of endothelium-derived nitric oxide. Circ J 66:583\u2013588","journal-title":"Circ J"},{"issue":"9","key":"132_CR22","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.amjcard.2006.12.044","volume":"99","author":"EI Skalidis","year":"2007","unstructured":"Skalidis EI, Zacharis EA, Tsetis DK et al (2007) Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. Am J Cardiol 99(9):1258\u20131262","journal-title":"Am J Cardiol"},{"issue":"4","key":"132_CR23","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","volume":"96","author":"A Frustaci","year":"1997","unstructured":"Frustaci A, Chimenti C, Bellocci F et al (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 96(4):1180\u20131184","journal-title":"Circulation."},{"issue":"4","key":"132_CR24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/SHK.0000000000000320","volume":"43","author":"LA Cox","year":"2015","unstructured":"Cox LA, van Eijk LT, Ramakers BP et al (2015) Inflammation induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo. Shock. 43(4):322\u2013326","journal-title":"Shock."},{"key":"132_CR25","doi-asserted-by":"crossref","unstructured":"Chua W, Purmah Y, Cardoso RV et al (2019) Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation. Eur Heart J 40(16):1268\u20131276","DOI":"10.1093\/eurheartj\/ehy815"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-021-00132-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s43044-021-00132-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-021-00132-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T15:44:41Z","timestamp":1670773481000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-021-00132-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1186\/s43044-021-00132-1","relation":{},"ISSN":["2090-911X"],"issn-type":[{"type":"electronic","value":"2090-911X"}],"subject":[],"published":{"date-parts":[[2021,1,14]]},"assertion":[{"value":"8 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erzurum Regional Education and Research Ethics Committee approved the study, and all the participants provided their written informed consent (Decision number: KAEK 2019\/10-110).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}